| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $630.7M | +12.9% |
| Cost of Revenue | $272.3M | +13.1% |
| Gross Profit | $358.3M | +12.8% |
| R&D Expense | $107.5M | +15.9% |
| SG&A Expense | $178.3M | +19.6% |
| Operating Income | $5.9M | +3.3% |
| Interest Expense | $40.0M | -32.1% |
| Pre-tax Income | -$40.6M | +38.1% |
| Income Tax | -$12.8M | +42.8% |
| Net Income | -$20.8M | +38.4% |
| EPS (Basic) | -$0.13 | +38.1% |
| EPS (Diluted) | -$0.13 | +38.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $137.5M | +59.0% |
| Accounts Receivable | $54.3M | +12.2% |
| Current Assets | $228.7M | +31.9% |
| Total Assets | $3.58B | +0.8% |
| Current Liabilities | $413.7M | +7.3% |
| Long-term Debt | $744.0M | -1.0% |
| Total Liabilities | $1.85B | +0.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $149.0M | +4.1% |
| Capital Expenditures | $3.7M | -8.5% |
| Investing Cash Flow | -$77.6M | +79.2% |
| Financing Cash Flow | -$19.2M | -107.3% |
| Free Cash Flow | $145.4M | +4.5% |
| Stockholders' Equity |
| $1.25B |
| +1.1% |